• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Product Classification

  • Print
  • Share
  • E-mail
New Search Back To Search Results
Device camera, ophthalmic, general-use
Regulation Description Ophthalmic camera.
Definition An ophthalmic camera intended to capture and store images of the eye and surrounding area for prescription use only.
Physical State The device is a self-contained unit consisting of hardware (lens, camera sensor), software (capable of storing and basic processing), and a light source.
Technical Method The images may be captured by use with or without mydriatic agents. The device makes use of a series of lenses to capture a clear, high-resolution, non-distorted image of the eye (e.g., retina). Light may be provided by sources such as LED, halogen or incandescent bulb; however, the optical radiation assessment shall not exceed a group 1 determination per ISO 15004-2:2007. The device shall also not incorporate the use of a reference database.
Target Area The target area is the eye (lid, orbit) and ocular tissues (anterior and posterior segment).
Regulation Medical Specialty Ophthalmic
Review Panel Ophthalmic
Product CodePJZ
Premarket Review Office of Device Evaluation (ODE)
Division of Ophthalmic and Ear, Nose and Throat Devices (DOED)
Diagnostic and Surgical Devices Branch (DSDB)
Submission Type 510(K) Exempt
Regulation Number 886.1120
Device Class 2
Total Product Life Cycle (TPLC) TPLC Product Code Report
GMP Exempt? No
    Note: Class II devices the Food and Drug Administration (FDA) has also published a list of class II (special controls) devices subject to certain limitations, that are exempt from premarket notification requirements under the Food and Drug Administration Modernization Act of 1997 (FDAMA) and the 21st Century Cures Act of 2016 (Cures Act). FDA believes that these exemptions will relieve manufacturers from the need to submit premarket notification submissions for these devices and will enable FDA to redirect the resources that would be spent on reviewing such submissions to more significant public health issues. FDA is taking this action in order to meet requirements of FDAMA and the Cures Act.
Implanted Device? No
Life-Sustain/Support Device? No
Third Party Review Not Third Party Eligible